Dipharma Group is highlighted on the market as one of the major European players in the field of Bulk Active Pharmaceutical Ingredients having a portfolio of more than 40 APIs, with DMFs lodged worldwide. We serve top ranking pharmaceutical companies in Europe, U.S.A. and Japan, supported by a fully equipped R&D Centre, consisting of more than 40 qualified researchers. Modern laboratory equipment and two pilot plants enable us to develop and optimize complex chemical synthetic processes. Our four plants, operating in full cGMP, with a total capacity of over 600 m3, have been regularly inspected by the U.S. FDA through the years. All above competencies and capabilities make Dipharma the right partner for Custom Synthesis. Our core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenations, Chiral Synthesis and Organometallic Chemistry.